IGF-1 (Insulin-like Growth Factor 1)
What It Is
IGF-1 is a hormone produced mainly by the liver in response to Growth Hormone (GH). It helps regulate:
- Growth
- Muscle repair
- Bone strength
- Cell regeneration
- Metabolism
It is one of the body’s major growth-signaling hormones.
Relationship to Growth Hormone
Pituitary gland → releases Growth Hormone → liver produces IGF-1 → tissues respond & grow
Doctors often measure IGF-1 because it remains more stable in the bloodstream than Growth Hormone itself.
What IGF-1 Does
Muscles
- Helps muscle recovery
- Supports protein synthesis
- Encourages muscle growth
Bones
- Supports bone density
- Important during childhood growth
- Helps maintain skeletal strength in adults
Brain & Cells
- Supports cellular survival
- Involved in nerve signaling
- May influence cognition & aging
Low IGF-1 May Be Associated With
- Aging
- Malnutrition
- Poor sleep
- Pituitary dysfunction
- Growth Hormone deficiency
Possible symptoms:
- Fatigue
- Reduced muscle mass
- Increased body fat
- Slower recovery
High IGF-1 May Be Associated With
- Excess Growth Hormone
- Acromegaly
- Certain tumors
- Performance-enhancing drug use
Possible symptoms:
- Enlarged hands/feet
- Joint pain
- Thickened facial features
- Elevated blood sugar risk
Researchers think the body faces a tradeoff:
Higher IGF-1:
- Better muscle maintenance
- Better recovery
- Stronger anabolic signaling
- More tissue growth
But possibly also:
- More cellular overstimulation
- Increased cancer growth risk if cancer cells already exist
- Faster cellular aging in some tissues
Why scientists worry about high IGF-1 in aging:
Cells divide more
IGF-1 tells cells to grow and reproduce. That is helpful for healing and muscle, but uncontrolled cell growth is also part of cancer biology.
Less cellular “cleanup”
Lower nutrient-signaling states may encourage processes like autophagy, where damaged cellular material gets recycled and removed.
Longevity studies
Some animal studies found that reduced IGF-1 signaling was associated with longer lifespan. Certain long-lived populations of humans also appear to have slightly lower IGF-1 activity.
But there is a balance:
Very low IGF-1 in elderly people can also be harmful because it may contribute to:
- Frailty
- Muscle wasting
- Weak bones
- Falls
- Poor recovery
So the modern view is usually:
Extremely high IGF-1 = potentially harmful
Extremely low IGF-1 = also potentially harmful
Healthy balance is likely the key.
This area of science is still actively debated and not fully settled.